These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32422321)
1. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF. Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321 [TBL] [Abstract][Full Text] [Related]
2. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats. Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224 [TBL] [Abstract][Full Text] [Related]
4. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment. Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815 [TBL] [Abstract][Full Text] [Related]
5. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction. Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790 [TBL] [Abstract][Full Text] [Related]
6. Interactions between the gut microbiome, associated metabolites and the manifestation and progression of heart failure with preserved ejection fraction in ZSF1 rats. Guivala SJ; Bode KA; Okun JG; Kartal E; Schwedhelm E; Pohl LV; Werner S; Erbs S; Thiele H; Büttner P Cardiovasc Diabetol; 2024 Aug; 23(1):299. PubMed ID: 39143579 [TBL] [Abstract][Full Text] [Related]
7. Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction. Bowen TS; Brauer D; Rolim NPL; Bækkerud FH; Kricke A; Ormbostad Berre AM; Fischer T; Linke A; da Silva GJ; Wisloff U; Adams V J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066440 [TBL] [Abstract][Full Text] [Related]
8. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction. Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455 [TBL] [Abstract][Full Text] [Related]
9. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction. Leite S; Cerqueira RJ; Ibarrola J; Fontoura D; Fernández-Celis A; Zannad F; Falcão-Pires I; Paulus WJ; Leite-Moreira AF; Rossignol P; López-Andrés N; Lourenço AP Circ Heart Fail; 2019 Jul; 12(7):e005596. PubMed ID: 31525070 [TBL] [Abstract][Full Text] [Related]
10. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome. van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881 [TBL] [Abstract][Full Text] [Related]
11. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility. Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823 [TBL] [Abstract][Full Text] [Related]
12. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction. Schauer A; Draskowski R; Jannasch A; Kirchhoff V; Goto K; Männel A; Barthel P; Augstein A; Winzer E; Tugtekin M; Labeit S; Linke A; Adams V ESC Heart Fail; 2020 Oct; 7(5):2123-2134. PubMed ID: 32710530 [TBL] [Abstract][Full Text] [Related]
13. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction. Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189 [TBL] [Abstract][Full Text] [Related]
14. Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction. Gao C; Xiong Z; Liu Y; Wang M; Wang M; Liu T; Liu J; Ren S; Cao N; Yan H; Drucker DJ; Rau CD; Yokota T; Huang J; Wang Y Circ Res; 2024 Aug; 135(5):614-628. PubMed ID: 39011638 [TBL] [Abstract][Full Text] [Related]